Menu Search
Equities

Cosmos Pharmaceutical Corp

3349:TYO

Cosmos Pharmaceutical Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)7,015.00
  • Today's Change-105.00 / -1.47%
  • Shares traded250.30k
  • 1 Year change-10.84%
  • Beta0.0980
Data delayed at least 20 minutes, as of Nov 14 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Cosmos Pharmaceutical Corp had little change in net income (from 23.80bn to 24.45bn) despite revenues that grew 16.59% from 827.70bn to 964.99bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 79.62% to 80.49%.
Gross margin19.88%
Net profit margin2.65%
Operating margin3.38%
Return on assets5.67%
Return on equity11.53%
Return on investment10.42%
More ▼

Cash flow in JPYView more

In 2024, Cosmos Pharmaceutical Corp increased its cash reserves by 13.88%, or 6.37bn. The company earned 55.18bn from its operations for a Cash Flow Margin of 5.72%. In addition the company generated 8.53bn cash from financing while 57.33bn was spent on investing.
Cash flow per share588.16
Price/Cash flow per share12.22
Book value per share2,992.83
Tangible book value per share2,986.85
More ▼

Balance sheet in JPYView more

Cosmos Pharmaceutical Corp has a Debt to Total Capital ratio of 10.16%, a higher figure than the previous year's 4.33%.
Current ratio0.7213
Quick ratio0.3209
Total debt/total equity0.1131
Total debt/total capital0.1016
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 20.00% and 2.71%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Grocery) industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.62%
Div growth rate (5 year)19.14%
Payout ratio (TTM)18.22%
EPS growth(5 years)4.96
EPS (TTM) vs
TTM 1 year ago		9.43
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.